Sarah Bertoli

France

Research Interests

Explore related searches

Professors in France Professors in Cancer Biology Cancer Biology professors in France

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Collaborators (5)

Richard F Schlenk

Head of trials office

Ruprecht Karls Universität Heidelberg

GERMANY

View details

Christian Thiede

University Hospital Carl Gustav Carus

GERMANY

View details

Ludovic Gabellier

FRANCE

View details

Adrien Contejean

FRANCE

View details

Alban Canali

FRANCE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Sarah Bertoli

Research Interests

Explore related searches

Contact this professor

Articles (10)

Clinico‐biological features, treatment and prognosis of primary myeloid sarcoma: A French retrospective multi‐centric observational study

Acute promyelocytic leukaemia associated with atypical basophilia

Targeting PP2A-dependent autophagy enhances sensitivity to ruxolitinib in JAK2V617F myeloproliferative neoplasms

Cost comparison of post-remission strategies in younger and older AML patients in France

Overlapping features of therapy-related and de novo NPM1-mutated AML

Prognostic Impact of Unsupervised Early Assessment of Bulk and Leukemic Stem Cell Measurable Residual Disease in Acute Myeloid Leukemia

Gilteritinib activity in refractory or relapsed FLT3-mutated acute myeloid leukemia patients previously treated by intensive chemotherapy and midostaurin: a study from the French AML Intergroup ALFA/FILO

Therapy-related Myeloid Neoplasms Following PARP Inhibitors: Real-life Experience

Phenotypically-defined stages of leukemia arrest predict main driver mutations subgroups, and outcome in acute myeloid leukemia

A scoring system for AML patients aged 70 years or older, eligible for intensive chemotherapy: a study based on a large European data set using the DATAML, SAL, and PETHEMA registries

Collaborators (5)

Richard F Schlenk

Christian Thiede

Ludovic Gabellier

Adrien Contejean

Alban Canali

Make your next move.